BRAINSTORM CELL THERAPEUTICS INC. — Form D

BRAINSTORM CELL THERAPEUTICS INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-21. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Irit ArbelDirectorJERUSALEM, L3
Mordechai S FriedmanDirectorHackensack, NJ
Alon PinkasDirectorNEW YORK, NY
Robert ShorrDirectorNEW YORK, NY
Malcolm S TaubDirectorHackensack, NJ
Uri S YablonkaDirectorHackensack, NJ
Anthony S FiorinoExecutive OfficerHackensack, NJ
Chaim S LebovitsExecutive OfficerHackensack, NJ
Liat SossoverExecutive OfficerNEW YORK, NY
Uri S YablonkaExecutive OfficerHackensack, NJ
Chen SchorDirectorNEW YORK, NY
Ralph KernExecutive OfficerNEW YORK, NY
Dr. Anthony PolverinoDirectorNEW YORK, NY
Arturo ArayaDirectorNEW YORK, NY
Arturo ArayaExecutive OfficerNEW YORK, NY
Dr. June AlmenoffDirectorNEW YORK, NY
Dr. Irit ArbelDirectorNEW YORK, NY
Malcolm TaubDirectorNEW YORK, NY
Chaim LebovitsExecutive OfficerNEW YORK, NY
Eyal RubinExecutive OfficerTEL AVIV, L3
Uri YablonkaDirectorNEW YORK, NY
Uri YablonkaExecutive OfficerNEW YORK, NY
Mordechai FriedmanDirectorNEW YORK, NY
Adrian S. HarelExecutive OfficerNEW YORK, NY
Mordechai S. FriedmanDirectorNEW YORK, NY

Other filings by this issuer (5)

FiledFormOfferingSold
2019-08-09D
2018-06-20D
2014-07-01D$10.5M$10.5M
2014-05-09D$2.5M$1.6M
2012-07-27D$207K$207K

More